$AERT
Aeries Technology, Inc. Stock $aert

$aert Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000182912624001000 Filed on February 20, 2024

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$18.90M		$0.00
YoY Change
Cost Of Revenue	$12.85M	$12.75M	$11.88M
YoY Change	23.89%
Gross Profit	$6.046M	$4.824M	$4.447M
YoY Change	160.83%
Gross Profit Margin	31.99%
Selling, General & Admin	$5.313M	$1.597M	$1.476M
YoY Change	162.37%	10.6%	400.79%
% of Gross Profit	87.88%	33.12%	33.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$343.0K	$334.0K	$327.0K
YoY Change
% of Gross Profit	5.67%	6.92%	7.35%
Operating Expenses	$5.313M	$1.597M	$1.476M
YoY Change	124.92%	10.6%	400.79%
Operating Profit	$733.0K	-$1.597M	-$1.476M
YoY Change	150.17%	10.6%	400.79%
Interest Expense	$115.0K	$75.62K	$3.509M
YoY Change	-95.39%	-91.54%	-45.76%
% of Operating Profit	15.69%
Other Income/Expense, Net	-$16.48M	$0.00	-$6.000K
YoY Change		-100.0%
Pretax Income	-$15.74M	-$1.522M	$2.033M
YoY Change	-11880.9%	337.22%	-67.07%
Income Tax	$557.0K	$679.0K	$218.0K
% Of Pretax Income			10.72%
Net Earnings	-$16.65M	-$1.522M	$2.033M
YoY Change	-12558.1%	337.22%	-67.07%
Net Earnings / Revenue	-88.1%
Basic Earnings Per Share	-$1.08
Diluted Earnings Per Share	-$1.08	-$0.15	$0.16
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.543M	$8.410K	$41.84K
YoY Change	13494.43%	-91.0%	-69.78%
Cash & Equivalents	$6.543M	$8.412K	$41.84K
Short-Term Investments
Other Short-Term Assets	$1.022M	$837.00	$3.336K
YoY Change	12163.02%	-99.79%	-99.2%
Inventory
Prepaid Expenses		$39.85K	$152.9K
Receivables	$18.15M	$14.38M	$13.76M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$32.00M	$49.09K	$198.1K
YoY Change	8768.99%	-89.98%	-64.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.538M	$9.528M	$10.10M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.558M	$49.99M	$49.36M
YoY Change	-99.34%	-78.58%	-78.77%
Other Assets	$1.812M	$4.033M	$4.226M
YoY Change		20365.85%	3570.86%
Total Long-Term Assets	$14.71M	$49.99M	$49.36M
YoY Change	-93.73%	-78.59%	-78.78%
TOTAL ASSETS
Total Short-Term Assets	$32.00M	$49.09K	$198.1K
Total Long-Term Assets	$14.71M	$49.99M	$49.36M
Total Assets	$46.71M	$50.04M	$49.56M
YoY Change	-80.13%	-78.61%	-78.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.771M	$6.352M	$5.774M
YoY Change	1048.45%	20161.11%	36485.11%
Accrued Expenses	$4.643M	$62.27K	$68.55K
YoY Change	10884.93%	-96.02%	-76.91%
Deferred Revenue
YoY Change
Short-Term Debt	$6.238M	$557.8K	$548.4K
YoY Change	3019.0%	176.2%	171.54%
Long-Term Debt Due	$13.00K	$13.00K	$12.00K
YoY Change
Total Short-Term Liabilities	$68.12M	$9.386M	$7.938M
YoY Change	1598.64%	422.38%	1442.6%
LONG-TERM LIABILITIES
Long-Term Debt	$1.141M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.923M	$1.002M	$446.8K
YoY Change	309.72%	-54.04%	-95.61%
Total Long-Term Liabilities	$5.064M	$1.002M	$446.8K
YoY Change	428.89%	-54.04%	-95.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$68.12M	$9.386M	$7.938M
Total Long-Term Liabilities	$5.064M	$1.002M	$446.8K
Total Liabilities	$80.04M	$10.39M	$8.385M
YoY Change	1511.2%	161.25%	-21.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$42.50M	-$10.24M	-$8.087M
YoY Change	842.8%	204.1%	-18.39%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$43.07M	-$10.24M	-$8.087M
YoY Change
Total Liabilities & Shareholders Equity	$46.71M	$50.04M	$49.56M
YoY Change	-80.13%	-78.61%	-78.74%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$16.65M	-$1.522M	$2.033M
YoY Change	-12558.1%	337.22%	-67.07%
Depreciation, Depletion And Amortization	$343.0K	$334.0K	$327.0K
YoY Change
Cash From Operating Activities	-$1.362M	-$33.44K	-$79.90K
YoY Change	3592.06%	-25.64%	-41.49%
INVESTING ACTIVITIES
Capital Expenditures	$328.0K	$476.0K	$258.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$67.00K	$0.00	$189.4M
YoY Change
Cash From Investing Activities	-$261.0K	$0.00	$189.4M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.279M	0.000	-189.3M
YoY Change	-74319.86%		-946723.0%
NET CHANGE
Cash From Operating Activities	-1.362M	-33.44K	-79.90K
Cash From Investing Activities	-261.0K	0.000	189.4M
Cash From Financing Activities	6.279M	0.000	-189.3M
Net Change In Cash	4.656M	-33.44K	30.10K
YoY Change	-10366.81%	-25.64%	-125.82%
FREE CASH FLOW
Cash From Operating Activities	-$1.362M	-$33.44K	-$79.90K
Capital Expenditures	$328.0K	$476.0K	$258.0K
Free Cash Flow	-$1.690M	-$509.4K	-$337.9K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001853044
CY2023Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet		usd
CY2023Q1	AERT	Forward Purchase Agreement Put Option Liability ForwardPurchaseAgreementPutOptionLiability		usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022Q4	AERT	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability		usd
	AERT	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability		usd
CY2022Q4	AERT	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
	AERT	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities		usd
CY2022Q4	AERT	Net Income Loss Attributable To Redeemable Noncontrolling Interests NetIncomeLossAttributableToRedeemableNoncontrollingInterests		usd
	AERT	Net Income Loss Attributable To Redeemable Noncontrolling Interests NetIncomeLossAttributableToRedeemableNoncontrollingInterests		usd
CY2022Q4	AERT	Comprehensive Income Loss Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossAttributableToRedeemableNoncontrollingInterests		usd
	AERT	Comprehensive Income Loss Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossAttributableToRedeemableNoncontrollingInterests		usd
CY2023Q3	AERT	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment		usd
CY2023Q4	AERT	Reclassification Of Negative Additional Paidin Capital ReclassificationOfNegativeAdditionalPaidinCapital		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	AERT	Gain On Lease Termination GainOnLeaseTermination		usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities		usd
	AERT	Change In Fair Value Of Derivative Warrant Liabilitie ChangeInFairValueOfDerivativeWarrantLiabilitie		usd
	AERT	Loss On Issuance Of Shares Against Accounts Payable LossOnIssuanceOfSharesAgainstAccountsPayable		usd
	AERT	Payment Of Promissory Note Liability PaymentOfPromissoryNoteLiability		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets		usd
	AERT	Settlement Of Accounts Payable Through Issuance Of Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors		usd
	AERT	Assumption Of Net Liabilities From Business Combination AssumptionOfNetLiabilitiesFromBusinessCombination		usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40920
	dei	Entity Registrant Name EntityRegistrantName	Aeries Technology, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1587626
	dei	Entity Address Address Line1 EntityAddressAddressLine1	60 Paya Lebar Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#08-13
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Paya Lebar Square
	dei	Entity Address City Or Town EntityAddressCityOrTown	Singapore
	dei	Entity Address Country EntityAddressCountry	SG
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	409051
	dei	City Area Code CityAreaCode	(919)
	dei	Local Phone Number LocalPhoneNumber	228-6404
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6543000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1131000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	1233000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	18152000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	13416000	usd
CY2023Q4	AERT	Prepaid Expenses And Other Current Assets Net Of Allowance PrepaidExpensesAndOtherCurrentAssetsNetOfAllowance	6000	usd
CY2023Q1	AERT	Prepaid Expenses And Other Current Assets Net Of Allowance PrepaidExpensesAndOtherCurrentAssetsNetOfAllowance	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7302000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4117000	usd
CY2023Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	1921000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	31997000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	20585000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3538000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3125000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6320000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5627000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1484000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1237000	usd
CY2023Q4	AERT	Longterm Investments Net Of Allowance LongtermInvestmentsNetOfAllowance	129000	usd
CY2023Q1	AERT	Longterm Investments Net Of Allowance LongtermInvestmentsNetOfAllowance	0	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	1558000	usd
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	1564000	usd
CY2023Q4	AERT	Other Assets Net Of Allowance OtherAssetsNetOfAllowance	1000	usd
CY2023Q1	AERT	Other Assets Net Of Allowance OtherAssetsNetOfAllowance	0	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1812000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2259000	usd
CY2023Q4	us-gaap	Assets Assets	46709000	usd
CY2023Q1	us-gaap	Assets Assets	34397000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7771000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2474000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2782000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2823000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1861000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1648000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6238000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1376000	usd
CY2023Q4	AERT	Forward Purchase Agreement Put Option Liability ForwardPurchaseAgreementPutOptionLiability	42256000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7210000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4201000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	68118000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12522000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1141000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	969000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4825000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4261000	usd
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1917000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	114000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	168000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3923000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3008000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	80038000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	20928000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9743000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	0	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7221000	usd
CY2023Q4	AERT	Accumulated Other Comprehensive Loss AccumulatedOtherComprehensiveLoss	-578000	usd
CY2023Q1	AERT	Accumulated Other Comprehensive Loss AccumulatedOtherComprehensiveLoss	-1349000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-42496000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6318000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-43072000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	12190000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1279000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-43072000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13469000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46709000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34397000	usd
CY2023Q4	AERT	Revenue Net RevenueNet	18897000	usd
CY2022Q4	AERT	Revenue Net RevenueNet	12691000	usd
	AERT	Revenue Net RevenueNet	52805000	usd
	AERT	Revenue Net RevenueNet	38027000	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	137000	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	125000	usd
CY2023Q4	AERT	Net Income Loss Attributable To Redeemable Noncontrolling Interests NetIncomeLossAttributableToRedeemableNoncontrollingInterests	154000	usd
CY2023Q4	us-gaap	Cost Of Revenue CostOfRevenue	12851000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	10373000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	37488000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	28685000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	6046000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	2318000	usd
	us-gaap	Gross Profit GrossProfit	15317000	usd
	us-gaap	Gross Profit GrossProfit	9342000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5313000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2025000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12321000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7898000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	5313000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	2025000	usd
	us-gaap	Operating Expenses OperatingExpenses	12321000	usd
	us-gaap	Operating Expenses OperatingExpenses	7898000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	733000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	293000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2996000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1444000	usd
CY2023Q4	AERT	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability	-17247000	usd
	AERT	Change In Fair Value Of Forward Purchase Agreement Put Option Liability ChangeInFairValueOfForwardPurchaseAgreementPutOptionLiability	-17247000	usd
CY2023Q4	AERT	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	852000	usd
	AERT	Change In Fair Value Of Derivative Warrant Liabilities ChangeInFairValueOfDerivativeWarrantLiabilities	852000	usd
CY2023Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	83000	usd
CY2022Q4	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	80000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	217000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	175000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	115000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	52000	usd
	us-gaap	Interest Expense InterestExpense	314000	usd
	us-gaap	Interest Expense InterestExpense	166000	usd
CY2023Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-50000	usd
CY2022Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	106000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	70000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	518000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16477000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	134000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16422000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	527000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15744000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	427000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13426000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1971000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	557000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	742000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1454000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1150000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-16301000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-315000	usd
	us-gaap	Profit Loss ProfitLoss	-14880000	usd
	us-gaap	Profit Loss ProfitLoss	821000	usd
CY2023Q4	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-44000	usd
CY2022Q4	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-45000	usd
	AERT	Net Income Loss Attributable To Redeemable Noncontrolling Interests NetIncomeLossAttributableToRedeemableNoncontrollingInterests	154000	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16411000	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-270000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15171000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	696000	usd
CY2023Q4	AERT	Weighted Average Shares Outstanding Of Class Ordinary Shares Basic And Diluted WeightedAverageSharesOutstandingOfClassOrdinarySharesBasicAndDiluted	15389062	shares
	AERT	Weighted Average Shares Outstanding Of Class Ordinary Shares Basic And Diluted WeightedAverageSharesOutstandingOfClassOrdinarySharesBasicAndDiluted	15389062	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-16301000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-315000	usd
	us-gaap	Profit Loss ProfitLoss	-14880000	usd
	us-gaap	Profit Loss ProfitLoss	821000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	6000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	143000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	159000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	788000	usd
CY2023Q4	AERT	Unrecognized Actuarial Loss On Employee Benefit Plan Obligations UnrecognizedActuarialLossOnEmployeeBenefitPlanObligations	26000	usd
CY2022Q4	AERT	Unrecognized Actuarial Loss On Employee Benefit Plan Obligations UnrecognizedActuarialLossOnEmployeeBenefitPlanObligations	76000	usd
	AERT	Unrecognized Actuarial Loss On Employee Benefit Plan Obligations UnrecognizedActuarialLossOnEmployeeBenefitPlanObligations	-27000	usd
	AERT	Unrecognized Actuarial Loss On Employee Benefit Plan Obligations UnrecognizedActuarialLossOnEmployeeBenefitPlanObligations	73000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-67000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-186000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-715000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16281000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-382000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15066000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	106000	usd
CY2023Q4	AERT	Comprehensive Income Loss Attributable To Noncontrolling Interest ComprehensiveIncomeLossAttributableToNoncontrollingInterest	43000	usd
CY2022Q4	AERT	Comprehensive Income Loss Attributable To Noncontrolling Interest ComprehensiveIncomeLossAttributableToNoncontrollingInterest	55000	usd
	AERT	Comprehensive Income Loss Attributable To Noncontrolling Interest ComprehensiveIncomeLossAttributableToNoncontrollingInterest	-108000	usd
	AERT	Comprehensive Income Loss Attributable To Noncontrolling Interest ComprehensiveIncomeLossAttributableToNoncontrollingInterest	-20000	usd
CY2023Q4	AERT	Comprehensive Income Loss Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossAttributableToRedeemableNoncontrollingInterests	162000	usd
	AERT	Comprehensive Income Loss Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossAttributableToRedeemableNoncontrollingInterests	162000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	16400000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	327000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	15336000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-86000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13469000	usd
CY2023Q2	AERT	Transition Period Adjustment Pursuant To Asc326 Net Of Tax TransitionPeriodAdjustmentPursuantToAsc326NetOfTax	-223000	usd
CY2023Q2	AERT	Adjusted Balances AdjustedBalances	13246000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	494000	usd
CY2023Q2	AERT	Other Comprehensive Loss OtherComprehensiveLoss	-14000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1374000	usd
CY2023Q2	AERT	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment	-10000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15090000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	927000	usd
CY2023Q3	AERT	Other Comprehensive Loss OtherComprehensiveLoss	-192000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	252000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16077000	usd
CY2023Q4	AERT	Share In Premerger Net Income ShareInPremergerNetIncome	194000	usd
CY2023Q4	AERT	Share In Premerger Others Comprehensive Income ShareInPremergerOthersComprehensiveIncome	8000	usd
CY2023Q4	AERT	Reverse Recapitalization Net Of Transaction Expenses ReverseRecapitalizationNetOfTransactionExpenses	-43609000	usd
CY2023Q4	AERT	Settlement Of Accounts Payable Through Issuance Of Shares SettlementOfAccountsPayableThroughIssuanceOfShares	903000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-16649000	usd
CY2023Q4	AERT	Other Comprehensive Loss OtherComprehensiveLoss	4000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-43072000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8696000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1358000	usd
CY2022Q2	AERT	Other Comprehensive Loss OtherComprehensiveLoss	-321000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9733000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-222000	usd
CY2022Q3	AERT	Other Comprehensive Loss OtherComprehensiveLoss	-327000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1057000	usd
CY2022Q3	AERT	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment	6000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10247000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-315000	usd
CY2022Q4	AERT	Other Comprehensive Loss OtherComprehensiveLoss	-67000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	1425000	usd
CY2022Q4	AERT	Net Changes In Net Stockholders Investment NetChangesInNetStockholdersInvestment	12000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11302000	usd
	us-gaap	Profit Loss ProfitLoss	-14880000	usd
	us-gaap	Profit Loss ProfitLoss	821000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1004000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	873000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1626000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2482000	usd
	AERT	Deferred Tax Benefit Expense DeferredTaxBenefitExpense	230000	usd
	AERT	Deferred Tax Benefit Expense DeferredTaxBenefitExpense	146000	usd
	AERT	Accrued Income From Longterm Investments AccruedIncomeFromLongtermInvestments	141000	usd
	AERT	Accrued Income From Longterm Investments AccruedIncomeFromLongtermInvestments	129000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1074000	usd
	AERT	Gain On Lease Termination GainOnLeaseTermination	13000	usd
	AERT	Others Others	50000	usd
	AERT	Others Others	1000	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	17247000	usd
	AERT	Change In Fair Value Of Derivative Warrant Liabilitie ChangeInFairValueOfDerivativeWarrantLiabilitie	852000	usd
	AERT	Loss On Issuance Of Shares Against Accounts Payable LossOnIssuanceOfSharesAgainstAccountsPayable	48000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6070000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2630000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	623000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	505000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	825000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	6200000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-416000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1737000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	451000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-177000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	-22000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	-1397000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	29000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4174000	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	926000	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	6452000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	910000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	438000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2318000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1062000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1388000	usd
	AERT	Issuance Of Loans To Affiliates IssuanceOfLoansToAffiliates	1730000	usd
	AERT	Issuance Of Loans To Affiliates IssuanceOfLoansToAffiliates	1041000	usd
	AERT	Payments Received For Loans To Affiliates PaymentsReceivedForLoansToAffiliates	1722000	usd
	AERT	Payments Received For Loans To Affiliates PaymentsReceivedForLoansToAffiliates	1011000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1070000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1418000	usd
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1748000	usd
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	1012000	usd
	AERT	Payment Of Promissory Note Liability PaymentOfPromissoryNoteLiability	1500000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	239000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	575000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	138000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-388000	usd
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	323000	usd
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	290000	usd
	AERT	Payment Of Deferred Transaction Costs PaymentOfDeferredTransactionCosts	2055000	usd
	AERT	Payment Of Deferred Transaction Costs PaymentOfDeferredTransactionCosts	434000	usd
	AERT	Net Change In Net Stockholders Investment NetChangeInNetStockholdersInvestment	10000	usd
	AERT	Net Change In Net Stockholders Investment NetChangeInNetStockholdersInvestment	-18000	usd
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	8666000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6474000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	444000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-17000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-51000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5412000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1293000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1131000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	351000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6543000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1644000	usd
	us-gaap	Interest Paid Net InterestPaidNet	253000	usd
	us-gaap	Interest Paid Net InterestPaidNet	171000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1057000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	789000	usd
	AERT	Unpaid Deferred Transaction Costs Included In Accounts Payable And Other Current Liabilities UnpaidDeferredTransactionCostsIncludedInAccountsPayableAndOtherCurrentLiabilities	908000	usd
	AERT	Unpaid Deferred Transaction Costs Included In Accounts Payable And Other Current Liabilities UnpaidDeferredTransactionCostsIncludedInAccountsPayableAndOtherCurrentLiabilities	569000	usd
	AERT	Equipment Acquired Under Finance Lease Obligations EquipmentAcquiredUnderFinanceLeaseObligations	313000	usd
	AERT	Equipment Acquired Under Finance Lease Obligations EquipmentAcquiredUnderFinanceLeaseObligations	82000	usd
	AERT	Property And Equipment Purchase Included In Accounts Payable PropertyAndEquipmentPurchaseIncludedInAccountsPayable	81000	usd
	AERT	Property And Equipment Purchase Included In Accounts Payable PropertyAndEquipmentPurchaseIncludedInAccountsPayable	9000	usd
	AERT	Settlement Of Accounts Payable Through Issuance Of Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors	855000	usd
	AERT	Assumption Of Net Liabilities From Business Combination AssumptionOfNetLiabilitiesFromBusinessCombination	38994000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80C_eus-gaap--NatureOfOperations_zNwG008hZWU9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 <span id="xdx_824_zHMLBjofOeO9">Nature of Operations</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Aeries Technology, Inc. (formerly Worldwide Webb Acquisition Corp. (“WWAC”), formed in the Cayman Islands on March 5, 2021) and its subsidiaries, excluding the fintech and investing business activities, is herein referred to as the “Company”, “ATI”, the “registrant”, “us,” “we” and “our” in these condensed consolidated financial statements. Aark Singapore Pte. Ltd. and its subsidiaries (“AARK”), excluding the fintech and investing business activities, is herein referred to as the “Carve-out Entity”. The Company offers a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client’s business operations. The Company has subsidiaries in India, Mexico, Singapore and the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Change in Fiscal Year</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 6, 2023, the Company’s Board of Directors approved a change in the Company’s fiscal year end from December 31 to March 31. The Company’s current fiscal year will run from April 1, 2023 through March 31, 2024. Year-over-year quarterly financial data continues to be comparative to prior periods as the months that comprise each fiscal quarter in the new fiscal year are the same as those in the Company’s historical financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Demerger and Business Combination</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 11, 2023, ATI entered into the Business Combination Agreement (the “Business Combination” or “Merger Agreement”), with WWAC Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and a direct wholly-owned subsidiary of ATI (“Amalgamation Sub”), and Aark Singapore Pte. Ltd. a Singapore private company limited by shares (“AARK”) (together with the Company, AARK, and Amalgamation Sub, the “Parties” and individually, a “Party”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">AARK was engaged in management consulting, fintech and investing business. However, only the management consulting business was subject to the Merger Agreement and therefore in connection with the Business Combination, AARK entered into a Demerger Agreement with Aarx Singapore Pte. Ltd. and their respective shareholders’ on March 25, 2023 to spin off the fintech business which was a part of AARK but not subject to the Merger Agreement. Subsequently, the AARK Board of Directors ratified two resolutions on May 24, 2023. These resolutions effectively spun off the investing business which was part of the Company but not subject to the Merger Agreement. These transactions will collectively be referred to as “Demerger Transactions”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the Merger Agreement, all AARK ordinary shares that were issued and outstanding prior to the effective time of the transaction remained issued and outstanding following the transaction and continued to be held by the Sole Shareholder (as defined below) of AARK. The Company issued a Class V share to ‘NewGen Advisors and Consultants DWC-LLC’ (“NewGen”). NewGen is a business associate of Mr. Raman Kumar (“Sole Shareholder”). NewGen has agreed to hold the Class V share to protect the interest of the Sole Shareholder, in the event of certain events, including a hostile takeover or the appointment or removal of directors at ATI level. While the Class V share does not carry any direct economic rights, it does carry voting rights equal to 26% which will ratchet up to 51% voting rights upon occurrence of extraordinary events at the ATI level. All of the shares of Amalgamation Sub that were issued and outstanding as of the transaction date were converted into a number of newly issued AARK ordinary shares. In accordance with principles of Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”) and based on the economic interest held by the shareholders post the transaction as well as the underlying rights, it was assessed that AARK is the accounting acquirer and ATI is the accounting acquiree. The Business Combination closed on November 6, 2023 (“Closing Date”) and resulted in ATI owning <span id="xdx_90C_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20231106__srt--OwnershipAxis__custom--AARKMember_zFD5c5nu8ccg" title="Ownership, percentage">38.24</span>% of the issued and outstanding shares of AARK and the Sole Shareholder of AARK owning the balance <span id="xdx_909_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_dp_c20231106__srt--OwnershipAxis__custom--AARKShareholdersMember_zTDhhjXt52z1" title="Ownership, percentage">61.76</span>%. Pursuant to the Business Combination, ATI has a right to appoint two out of the three directors on the Board of AARK and therefore has an ability to control the activities undertaken by AARK in ordinary course of business, resulting in AARK being classified as a subsidiary of ATI. Finally, the Business Combination has been accounted for as reverse recapitalization. Refer to the section <i>“Reverse Recapitalization”</i> below for details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Reverse Recapitalization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As mentioned above – <i>Demerger and Business Combination</i>, the Business Combination was closed on November 6, 2023 and has been accounted for as a reverse recapitalization because AARK has been determined to be the accounting acquirer under ASC 805 based on the evaluation of the following facts and circumstances taken into consideration:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td> <td style="width: 0.25in; text-align: left">●</td> <td style="text-align: justify">The Sole Shareholder, who controlled AARK prior to the Business Combination, will retain a majority of the outstanding shares of ATI after giving effect to the Exchange Agreements. The Exchange Agreements are further discussed in Note 11;</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td> <td style="width: 0.25in; text-align: left">●</td> <td style="text-align: justify">AARK has the ability to elect a majority of the members of ATI’s governing body;</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td> <td style="width: 0.25in; text-align: left">●</td> <td style="text-align: justify">AARK’s executive team makes up the executive team of ATI;</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td> <td style="width: 0.25in; text-align: left">●</td> <td style="text-align: justify">AARK represents an operating entity (group) with operating assets, revenues, and earnings significantly larger than WWAC.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under a reverse recapitalization, while ATI was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of pre-combination AARK issuing stock for the net assets of ATI, accompanied by a recapitalization. The net assets of ATI have been stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of pre-combination AARK and relate to the management consulting business. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immediately following the Business Combination, there were <span id="xdx_900_eus-gaap--SharesIssued_iI_pip0_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLuozYTNPNlk" title="Share issued">15,257,666</span> Class A ordinary shares outstanding with a par value of $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zT8zZ5ZZ6Z8d" title="Common stock, par value">0.0001</span>. Additionally, there were <span id="xdx_900_ecustom--PurchaseOfAdditionalShares_pip0_c20230401__20231231__us-gaap--AwardTypeAxis__custom--PrivatePlacementWarrantsMember_z4uG62oaeiNd" title="Purchase of additional shares">9,527,810</span> Private Placement Warrants (defined below) and <span id="xdx_909_ecustom--PurchaseOfAdditionalShares_pip0_c20230401__20231231__us-gaap--AwardTypeAxis__custom--PublicWarrantsMember_zARLuLc9tnBj" title="Purchase of additional shares">11,499,991</span> Public Warrants (defined below) outstanding with a right to purchase <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_c20231231_zKz6hdZrIEPj" title="Warrants outstanding">21,027,801</span> Class A ordinary shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Upon closing of the Business Combination, the total number of ATI’s Class A ordinary shares issued and outstanding was <span id="xdx_908_eus-gaap--SharesIssued_iI_pip0_c20231231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesClassAMember_zcAjvgl08Bgk" title="Shares issued"><span id="xdx_900_ecustom--ShareOutstanding_iI_pip0_c20231231__us-gaap--StatementEquityComponentsAxis__custom--OrdinarySharesClassAMember_zRKfWMBm4nG9" title="Share outstanding">15,257,666</span></span>. Further, certain Class A ordinary shareholders entered into non-redemption agreements executed on November 3, 2023 and November 5, 2023, to reverse redemptions for an aggregate of 1,652,892 Class A ordinary shares while waiving their right to receive any “Bonus Shares” issued under the Business Combination Agreement. In connection with the closing, holders of <span id="xdx_90E_ecustom--RedemptionOfShares_iI_pip0_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqSyCwQMl7Yg" title="Redemption of shares">2,697,052</span> Class A ordinary shares of ATI were redeemed at a price per share of approximately $<span id="xdx_907_ecustom--RedemptionPricePerShare_iI_pip0_c20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxjaKHegEsLi" title="Redemption price">10.69</span>. AARK incurred approximately $<span id="xdx_906_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn3n3_c20231231_zbDE8ByhlIK3" title="Transaction costs relating to business combination">3,697</span> in transaction costs relating to the Business Combination and recorded those costs against additional paid-in capital in the condensed consolidated balance sheet.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The number of Class A ordinary shares issued and outstanding immediately following the consummation of the Business Combination were:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--ScheduleOfconsummationOfBusinessCombinationTableTextBlock_pn3n3_zPRMsI6S8a2g" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Nature of Operations (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zSwfy3ulz2xl" style="display: none">Schedule of consummation of Business Combination</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_491_20231231_zg86zHm6axI6" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--PublicShareholdersRedeemableClassSharesIncludingBonusShares_iI_pip0_z52kxOsepgK4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Public Shareholders (Redeemable Class A ordinary shares), including Bonus Shares<sup id="xdx_F4E_zHTyf2Y0MVzc">(1)</sup></td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">3,157,469</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--SharesHeldByWorldwideWebbAcquisitionSponsorLlcSponsorAndOtherInitialHolders_iI_pip0_z2DoiaRcfFJ9" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shares held by Worldwide Webb Acquisition Sponsor, LLC (the “Sponsor”) and other initial holders<sup id="xdx_F4E_zYwyxLZ41ewd">(2)(3)</sup></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,750,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--SharesHeldByInnovoConsultancyDmcc_iI_pip0_zmddQzsOV6J8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shares held by Innovo Consultancy DMCC<sup id="xdx_F4E_zGpSZ2NkjUu3">(4)</sup></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,638,530</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--SharesHeldByFpaHolders_iI_pip0_zBkfXK25rgGh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shares held by FPA Holders<sup id="xdx_F48_znvjXcRXIOH4">(5)</sup></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">3,711,667</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--SharesIssued_iI_pip0_zCDM0hCC81J2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total<sup id="xdx_F45_zN74Eoqanm0c">(6)</sup></td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">15,257,666</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F07_zUY2tNiqJ5Fa" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F1E_z2xVxlVD9LN7" style="text-align: justify"> Includes 87,133 Bonus Shares issued to the Company’s public shareholders and 1,024,335 “Extension Shares” issued to certain holders of Class A ordinary shares (the “Holders”) in accordance with the Non-Redemption Agreement entered into between WWAC, the Sponsor, and the Holders of Class A ordinary shares. Also includes 288,333 shares purchased by the Forward Purchase Agreement holders in the open market or via redemption reversals prior to the consummation of the Business Combination.</td> </tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F0B_zeZ3nkqrsxI3" style="width: 0.25in; text-align: left">(2)</td> <td id="xdx_F1B_z1JFr2J2ty16" style="text-align: justify"> Includes 1,500,000 Class A ordinary shares issued to the Sponsor and 1,250,000 Class A ordinary shares issued to certain anchor investors upon conversion of Class B ordinary shares concurrently with the consummation of the Business Combination. 3,000,000 Class B ordinary shares were forfeited by the Sponsor upon the consummation of the Business Combination.</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F09_zePOtR8I5C2l" style="width: 0.25in; text-align: left">(3)</td> <td id="xdx_F11_zL21Sx0iYmai" style="text-align: justify"> Does not include (i) 1,500,000 Class B ordinary shares forfeited upon the consummation of the Business Combination, or (ii) 1,500,000 Class B ordinary shares forfeited pursuant to a Support Agreement with the Sponsor.</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F0D_zXuPht0msoN7" style="width: 0.25in; text-align: left">(4)</td> <td id="xdx_F1F_zDBHcYmiz4H1" style="text-align: justify"> Includes (i) 3,000,000 Class A Shares reissued against 3,000,000 Class B Shares forfeited by the Sponsor upon consummation of the Business Combination as per (2) above, and (ii) 2,638,530 remaining Bonus Shares issued to Innovo.</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F0A_zM7i1oxx76Oc" style="width: 0.25in; text-align: left">(5)</td> <td id="xdx_F12_zRRBajNd5CJ3" style="text-align: justify"> Represents a new issuance of Class A ordinary shares to the Forward Purchase Agreement holders in accordance with the Forward Purchase Agreement.</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F07_zeMcIrBO7z39" style="width: 0.25in; text-align: left">(6)</td> <td id="xdx_F17_zcYshuyTFrsi" style="text-align: justify"> Does not include 10,000 AARK ordinary shares and 655,788 Aeries Technology Group Business Accelerators Private Limited’s ordinary shares that represent noncontrolling interest in AARK. These shares will be exchangeable (together with the proportionate reduction in the voting power of the Class V Share, and in the case of the exchange of all AARK ordinary shares, the forfeiture and cancellation of the Class V Share) into shares in Aeries Technology, Inc. in connection with the Exchange Agreements, which is further discussed in Note 11.</td> </tr> </table> <p id="xdx_8A8_zk3kqONj99g2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table reconciles the elements of the Business Combination to the change in Net shareholders’ investment and additional paid-in capital on the condensed consolidated statement of changes in redeemable noncontrolling interest and shareholders’ equity (deficit) for the nine months and three months ended December 31, 2023:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfReconcilesOfBusinessCombinationTableTextBlock_pn3n3_zzYjClekNPO4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Nature of Operations (Details 1)"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BE_zqOomxhoNbsd" style="display: none">Schedule of reconciles of business combination</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_493_20230401__20231231_zgg16v6KRQmb" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: left"><b>Schedule of cash and net liabilities assumed pursuant to Business Combination</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Amount</b></td> <td style="padding-bottom: 1pt; text-align: left"><b> </b></td></tr> <tr id="xdx_407_ecustom--BalanceInCompanyTrustAccount_pn3n3_zgtH1RuMYv4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Balance in Company trust account</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">40,402</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--OutflowOnAccountOfRedemptionPayments_pn3n3_zcwOUGNvEqY1" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Outflow on account of redemption payments</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(18,795</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--PrepaymentForRecycleShareUnderForwardPurchaseAgreement_pn3n3_zV6KpiaJwyn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Prepayment for recycle share under forward purchase agreement</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(3,083</td> <td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--PaymentsUnderNonredemptionAgreements_pn3n3_zGYq1axD4nui" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Payments under Non-redemption agreements</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(9,672</td> <td style="text-align: left">)</td></tr> <tr id="xdx_407_ecustom--PaymentToContinentalStockTransferForServicesProvidedInRelationToBusinessCombination_pn3n3_zREUDQlz7pRc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Payment to Continental Stock Transfer for services provided in relation to the Business Combination</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(186</td> <td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--NetCashAcquiredInBusinessCombination_iI_pn3n3_z90sKPZUtfZb" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left"><b>Net cash acquired in Business Combination</b></td> <td style="width: 1%"><b> </b></td> <td style="width: 1%; text-align: left"><b> </b></td> <td style="width: 9%; text-align: right"><b>8,666</b></td> <td style="width: 1%; text-align: left"><b> </b></td></tr> <tr id="xdx_405_ecustom--AssumedNetLiabilitiesOfAtiOnClosingDate_iI_pn3n3_zqbdS47HllY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Assumed net liabilities of ATI on Closing Date<sup id="xdx_F47_zQHSUjVrqvRi">(1)</sup></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(38,994</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40A_ecustom--PrecombinationTransactionCosts_iI_pn3n3_zCCnbV6Azqne" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Pre-combination transaction costs</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(3,697</td> <td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--TransferredToRedeemableNciOnConsolidation_iI_pn3n3_z29FXzKWg0fb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Transferred to Redeemable Noncontrolling Interest (“NCI”) pursuant to Business Combination</td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right">(4,465</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_ecustom--ParValueOfClassOrdinarySharesIssued_pn3n3_zOmlWsnOfpd3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Par value of Class A ordinary shares issued</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_ecustom--NetChargeToAdditionalPaidincapitalAsResultOfBusinessCombinationReportedInStockholdersDeficit_iI_pn3n3_zi44u85ahpek" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Net charge to Additional paid-in-capital as a result of the Business Combination reported in Shareholders’ equity (deficit)</td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(38,492</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F08_zgKogReRIAz6" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F15_zimSWOYx5A47" style="text-align: justify"> Includes liability pursuant to warrants and Forward Purchase Agreement. Refer Note 14 for details</td> </tr> </table> <p id="xdx_8A6_zxJ326AuErF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the Business Combination, the Company’s Class A ordinary shares trades under the ticker symbol “AERT” and its public warrants (the “Public Warrants”) trade under the ticker symbol “AERTW” on the Nasdaq Stock Market. Prior to the consummation of the Business Combination, the Company’s common shares were traded on Nasdaq Stock Market under the symbol “WWAC.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	21027801	shares
CY2023Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3697000	usd
CY2023Q4	AERT	Public Shareholders Redeemable Class Shares Including Bonus Shares PublicShareholdersRedeemableClassSharesIncludingBonusShares	3157469	shares
CY2023Q4	AERT	Shares Held By Worldwide Webb Acquisition Sponsor Llc Sponsor And Other Initial Holders SharesHeldByWorldwideWebbAcquisitionSponsorLlcSponsorAndOtherInitialHolders	2750000	shares
CY2023Q4	AERT	Shares Held By Innovo Consultancy Dmcc SharesHeldByInnovoConsultancyDmcc	5638530	shares
CY2023Q4	AERT	Shares Held By Fpa Holders SharesHeldByFpaHolders	3711667	shares
CY2023Q4	us-gaap	Shares Issued SharesIssued	15257666	shares
	AERT	Balance In Company Trust Account BalanceInCompanyTrustAccount	40402000	usd
	AERT	Outflow On Account Of Redemption Payments OutflowOnAccountOfRedemptionPayments	-18795000	usd
	AERT	Prepayment For Recycle Share Under Forward Purchase Agreement PrepaymentForRecycleShareUnderForwardPurchaseAgreement	-3083000	usd
	AERT	Payments Under Nonredemption Agreements PaymentsUnderNonredemptionAgreements	-9672000	usd
	AERT	Payment To Continental Stock Transfer For Services Provided In Relation To Business Combination PaymentToContinentalStockTransferForServicesProvidedInRelationToBusinessCombination	-186000	usd
	AERT	Net Cash Acquired In Business Combination NetCashAcquiredInBusinessCombination	8666000	usd
	AERT	Assumed Net Liabilities Of Ati On Closing Date AssumedNetLiabilitiesOfAtiOnClosingDate	-38994000	usd
	AERT	Precombination Transaction Costs PrecombinationTransactionCosts	-3697000	usd
	AERT	Transferred To Redeemable Nci On Consolidation TransferredToRedeemableNciOnConsolidation	-4465000	usd
	AERT	Par Value Of Class Ordinary Shares Issued ParValueOfClassOrdinarySharesIssued	-2000	usd
	AERT	Net Charge To Additional Paidincapital As Result Of Business Combination Reported In Stockholders Deficit NetChargeToAdditionalPaidincapitalAsResultOfBusinessCombinationReportedInStockholdersDeficit	-38492000	usd
CY2023Q4	AERT	Shareholders Equity Deficit ShareholdersEquityDeficit	43072000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6543000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zR56FYojggt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_zg92MDQemcx">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, revenue recognition, allowance for credit losses, stock-based compensation, fair valuation of Forward Purchase Agreement (“FPA”) put option liabilities and private warrant liabilities, useful lives of property and equipment, accounting for income taxes, determination of incremental borrowing rates used for operating lease liabilities and right-of-use assets, obligations related to employee benefits and carve-out of financial statements, including the allocation of assets, liabilities and expenses. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to the Company at the time that these estimates and judgments were made. Actual results could differ from those estimates.</p>
	AERT	Redemption Shares RedemptionShares	288333	shares
CY2023Q4	AERT	Prepayment Amount PrepaymentAmount	42760000	usd
	AERT	Underlying Consideration Amount UnderlyingConsiderationAmount	39678000	usd
	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p id="xdx_84C_eus-gaap--DerivativesMethodsOfAccountingNonhedgingDerivatives_zr7IMVzGtTui" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_zkzDWgCxa3S">Derivative Financial Instruments and FPA Put Option Liability</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the Warrants (defined below) in accordance with the guidance contained in ASC 815-40 under which the Instruments (as defined below) do not meet the criteria for equity treatment and must be recorded as liabilities. The Company accounts for the FPA put option liability as a financial liability in accordance with the guidance in ASC 480-10. Warrants and FPA are collectively referred as the “Instruments”. The Instruments are subjected to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations. See Note 12 for further discussion of the pertinent terms of the Warrants and Note 14 for further discussion of the methodology used to determine the value of the Warrants and FPA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, the Company settled vendor balances mounting to $ <span id="xdx_90B_ecustom--SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors_pn3n3_c20230401__20231231_zrdfhW3coO47" title="Settlement of accounts payable through issuance of shares to vendors">855</span> owed to certain vendors by issuing <span id="xdx_901_eus-gaap--SharesIssued_iI_pip0_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOfS13P5bEeg" title="Shares issued">361,388</span> Class A ordinary shares. If the volume weighted average price (“VWAP”) of the Class A ordinary shares over the three trading days immediately preceding the agreement date is higher than the VWAP over the three trading days immediately preceding the six-month anniversary from the agreement date, additional Class A ordinary shares of ATI would need to be issued for the difference. This represents a derivative financial instrument written by the Company which has been accounted for in accordance with the guidance contained in ASC 815-40 including subsequent re-measurement at fair value with the changes being recognized in Company’s condensed consolidated statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value at inception and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the condensed consolidated balance sheets as current or noncurrent based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	AERT	Settlement Of Accounts Payable Through Issuance Of Shares To Vendors SettlementOfAccountsPayableThroughIssuanceOfSharesToVendors	855000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zfl3XkBUlhQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86F_zAwfYB2d7858">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, accounts receivable, loans to affiliates, and investments. The Company holds cash at financial institutions that the Company believes are high credit quality financial institutions and limits the amount of credit exposure with any one bank and conducts ongoing evaluations of the creditworthiness of the banks with which it does business. As of December 31, 2023 and March 31, 2023, there were one and four customers, respectively, that represented 10% or greater of the Company’s accounts receivable balance. The Company expects limited credit risk arising from its long-term investments as these primarily entail investments in the Company’s affiliates that have a credit rating that is above the minimum allowable credit rating defined in the Company’s investment policy. As a part of its risk management process, the Company limits its credit risk with respect to long-term investments by performing periodic evaluations of the credit standing of counterparties to its investments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In respect of the Company’s revenue, there were three and four customers that each accounted for more than <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z4HsTn12hK1l" title="Concentration of credit risk, percentage"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zCVIo3FEBbPg" title="Concentration of credit risk, percentage"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zrokLzDETO2g" title="Concentration of credit risk, percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zfwmbYdSYnig" title="Concentration of credit risk, percentage">10</span></span></span></span>% of total revenue for the nine months ended December 31, 2023 and 2022, respectively; and there were two and five customers that accounted for more than <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20231001__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z6TZQ2K28eAb" title="Concentration of credit risk, percentage"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zLFZxA2Rnwig" title="Concentration of credit risk, percentage">10</span></span>% of total revenue for the three months ended December 31, 2023 and 2022, respectively. The following table shows the amount of revenue derived from each customer exceeding <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20231001__20231231__srt--MajorCustomersAxis__custom--CustomerMember_zBVJBFXV5O0i" title="Concentration of credit risk, percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__srt--MajorCustomersAxis__custom--CustomerMember_zQRBEirIMXKi" title="Concentration of credit risk, percentage"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20221001__20221231__srt--MajorCustomersAxis__custom--CustomerMember_zQZKP8nHIPU1" title="Concentration of credit risk, percentage"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__srt--MajorCustomersAxis__custom--CustomerMember_ztNp8YquNzl5" title="Concentration of credit risk, percentage">10</span></span></span></span>% of the Company’s revenue during the three and nine months ended December 31, 2023 and 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfCededCreditRiskByReinsurerTextBlock_pip0_zi7L0qNUjEg7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B1_z6aoI8nJuZP5" style="display: none">Schedule of Concentration of credit risk</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended<br/> December 31,</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> <p style="margin-top: 0; margin-bottom: 0">Nine Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">December 31,</p></td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; vertical-align: top; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>2022</b></td> <td style="padding-bottom: 1pt"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Customer 1</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20231001__20231231__srt--MajorCustomersAxis__custom--CustomerOneMember_zVAZNQoOarAc" title="Concentration of credit risk, percentage">13.9</span></td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20221001__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember_z65ckmJStBO5" title="Concentration of credit risk, percentage">16.2</span></td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__srt--MajorCustomersAxis__custom--CustomerOneMember_zG8rsmM5REY4" title="Concentration of credit risk, percentage">14.4</span></td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember_za3W3glE0cml" title="Concentration of credit risk, percentage">16.5</span></td> <td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer 2</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20231001__20231231__srt--MajorCustomersAxis__custom--CustomerTwoMember_zxMjmsIChUi5" title="Concentration of credit risk, percentage">12.9</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20221001__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember_zSf0lMf70OF9" title="Concentration of credit risk, percentage">15.6</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__srt--MajorCustomersAxis__custom--CustomerTwoMember_zqkjZ69iVW2i" title="Concentration of credit risk, percentage">12.7</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember_zr7bTbub8Kd" title="Concentration of credit risk, percentage">15.4</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer 3</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20221001__20221231__srt--MajorCustomersAxis__custom--CustomerThreeMember_zjrvwDcFvMPd" title="Concentration of credit risk, percentage">14.7</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20230401__20231231__srt--MajorCustomersAxis__custom--CustomerThreeMember_zMtNwUweJrfl" title="Concentration of credit risk, percentage">10.3</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__srt--MajorCustomersAxis__custom--CustomerThreeMember_zlJfFKmgwp8d" title="Concentration of credit risk, percentage">12.8</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer 4</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20221001__20221231__srt--MajorCustomersAxis__custom--CustomerFourMember_zZMda5TCCEZ1" title="Concentration of credit risk, percentage">10.0</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220401__20221231__srt--MajorCustomersAxis__custom--CustomerFourMember_z3CIHEnXHDxj" title="Concentration of credit risk, percentage">10.1</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Customer 5</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20221001__20221231__srt--MajorCustomersAxis__custom--CustomerFiveMember_zydoXMYZogse" title="Concentration of credit risk, percentage">10.0</span></td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">n/a</td> <td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84A_eus-gaap--ReceivablesPolicyTextBlock_zvct20qCdzKd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_861_zbDfX1o37Wnl">Accounts receivable, net</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records a receivable when an unconditional right to consideration exists, such that only the passage of time is required before payment of consideration is due. Timing of revenue recognition may differ from the timing of invoicing to customers. If revenue recognized on a contract exceeds the billings, then the Company records an unbilled receivable for that excess amount, which is included as part of accounts receivable, net in the Company’s condensed consolidated balance sheets.</p> <p id="xdx_8A4_zo7NZ0P4rjHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the Company’s adoption of ASU 2016-13, Topic 326 Financial Instruments – Credit Losses (“Topic 326”), the accounts receivable balance was reduced by an allowance for doubtful accounts that was determined based on the Company’s assessment of the collectability of customer accounts. Under Topic 326, accounts receivable are recorded at the invoiced amount, net of allowance for credit losses. The Company regularly reviews the adequacy of the allowance for credit losses based on a combination of factors. In establishing any required allowance, management considers historical losses adjusted for current market conditions, the current receivables aging, current payment terms and expectations of forward-looking loss estimates. Allowance for credit losses was $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20231231_zBAjGE5w6be6" title="Allowance for credit losses">1,233</span> as of December 31, 2023 and allowance for doubtful accounts was $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn3n3_c20230331_zf1dDAIK8YK6" title="Allowance for credit losses">0</span> as of March 31, 2023, and is classified within “Accounts Receivable, net” in the condensed consolidated balance sheets. See “Recent accounting pronouncements adopted” section below for information pertaining to the adoption of Topic 326.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables provides details of the Company’s allowance for credit losses:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 0.75in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--SecuritiesBorrowedAllowanceForCreditLossTableTextBlock_pn3n3_zM0OUsNJl0Ka" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B6_zQmBWZGsWCb8" style="display: none">Schedule of allowance for credit losses</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_492_20230401__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zDohbuHIRTd1" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended<br/> December 31,<br/> 2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pn3n3_zSzh63EeRlbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Opening balance as of March 31, 2023</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1156">-</span></td> <td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--TransitionPeriodAdjustmentOnAccountsReceivablesThroughRetainedEarningsPursuantToAsc326_pn3n3_znWbpdAI51Ba" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left; padding-bottom: 1pt">Transition period adjustment on accounts receivables (through retained earnings) pursuant to ASC 326</td> <td style="width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">149</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AdjustedBalance_pn3n3_z6VdG2FvQcne" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Adjusted balance as of April 1, 2023</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">149</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--AdditionsChargedToCostAndExpense_pn3n3_zNKczRyAW3V4" style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Additions charged to cost and expense</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">1,084</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pn3n3_z0jBychpgWbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt">Closing balance as of December 31, 2023</td> <td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,233</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zOAFyswx2jr6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1233000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	AERT	Longterm Investment Net Of Allowance LongtermInvestmentNetOfAllowance	129000	usd
	AERT	Schedule Of Accounting For Transaction Cost In Relation To Reverse Recapitalization And Related Impact On The Income Tax ScheduleOfAccountingForTransactionCostInRelationToReverseRecapitalizationAndRelatedImpactOnTheIncomeTax	<table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--ScheduleOfAccountingForTransactionCostInRelationToReverseRecapitalizationAndRelatedImpactOnTheIncomeTax_pn3n3_zIyZEZ32zuIf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Restatement of Previously Issued Carve-out Consolidated Financial Statements (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B4_zVZJhBv2sUe3" style="display: none">Schedule of the restatement on the affected financial statement</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: left"> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: -0.25in; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Particulars</b></span></p></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Previously </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reported </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2022</b></span></p></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restatement </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustment </b></span></p></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As Restated</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,<br/> 2022</b></span></p></td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling, general and administrative expenses</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0DLosLD5fkk" style="width: 9%; text-align: right" title="Selling, administrative and general expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,202</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zGSgAyPF0C19" style="width: 9%; text-align: right" title="Selling, administrative and general expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(304</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--SellingGeneralAndAdministrativeExpenses_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zddbGvE86Vwl" style="width: 9%; text-align: right" title="Selling, administrative and general expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,898</span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total operating expenses</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--OperatingExpenses_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCxBM1Dd4Ond" style="text-align: right" title="Total operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,202</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--OperatingExpenses_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zQvRpgcCciz8" style="text-align: right" title="Total operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(304</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--OperatingExpenses_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zxrT3zZYqlac" style="text-align: right" title="Total operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,898</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income from operations</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--OperatingIncomeLoss_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZTXeKrr9Dic" style="text-align: right" title="Income from operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,140</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--OperatingIncomeLoss_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zzDXKUUJHDTj" style="text-align: right" title="Income from operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">304</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--OperatingIncomeLoss_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zLTt2jeWST56" style="text-align: right" title="Income from operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,444</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income before income taxes</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--IncomeLossAttributableToParent_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ab3rayQy4i" style="text-align: right" title="Income before income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,667</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--IncomeLossAttributableToParent_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zNnFjh9Tqxmi" style="text-align: right" title="Income before income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">304</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--IncomeLossAttributableToParent_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zIZlBmcuAulg" style="text-align: right" title="Income before income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,971</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZQaqQIwdDwh" style="text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">517</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zLTQ30OEqZI6" style="text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">304</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--NetIncomeLoss_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zCfCg20fuMX1" style="text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">821</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Net income attributable to noncontrolling interest<sup>(1)</sup></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fKDEp_z56wHNyKENhc" style="text-align: right" title="Less: Net income attributable to NCI"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_fKDEp_zjC4Oc763f62" style="text-align: right" title="Less: Net income attributable to NCI"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--IncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_fKDEp_zFxSFisrlYkb" style="text-align: right" title="Less: Net income attributable to NCI*"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income attributable to controlling interest</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--NetIncomeAttributableToControllingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zN8LDWSGG7I7" style="text-align: right" title="Net income attributable to controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--NetIncomeAttributableToControllingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z0tOkDIkbGd3" style="text-align: right" title="Net income attributable to controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--NetIncomeAttributableToControllingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zT6nAvf11EFi" style="text-align: right" title="Net income attributable to controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">696</span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td> <td id="xdx_F08_z8qah68Oltaj" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F1B_zYPVdK2DWXg7" style="text-align: justify"> The change in net income attributable to noncontrolling interest comprises of two impacts i.e., consequential impact on account of the change in accounting for transaction costs as set out above and change in the percentage attributable to noncontrolling interest based on the note discussed below.</td> </tr> </table>
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1022000	usd
CY2022Q4	AERT	Assets And Liabilities AssetsAndLiabilities	304000	usd
	AERT	Schedule Net Income Attributable To Noncontrolling Interest ScheduleNetIncomeAttributableToNoncontrollingInterest	<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleNetIncomeAttributableToNoncontrollingInterest_pn3n3_zYOKmIqRUdE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Restatement of Previously Issued Carve-out Consolidated Financial Statements (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B4_znzxZDzLT1T" style="display: none">Schedule of unaudited consolidated financial information</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Particulars</td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As Previously </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Reported </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31,<br/> 2022</b></p></td> <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Restatement </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Adjustment</b></p></td> <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td> <td style="padding-bottom: 1pt; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>As Restated</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31,<br/> 2022</b></p></td> <td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left">In the Statement of Operations</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 64%; text-align: left">Net income attributable to noncontrolling interest</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1gYtt1v9EN5" style="width: 9%; text-align: right" title="Net income attributable to noncontrolling interest">68</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_983_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__srt--RestatementAdjustmentMember_z2ZnH5jtFela" style="width: 9%; text-align: right" title="Net income attributable to noncontrolling interest">19</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220401__20221231__srt--RestatementAxis__custom--AsRestatedMember_zMEW70XfhWD7" style="width: 9%; text-align: right" title="Net income attributable to noncontrolling interest">87</td> <td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	6238000	usd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1376000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0080	pure
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0120	pure
	AERT	Legal Consultancy Services LegalConsultancyServices	This resulted in a reduction in the total amount owed by ATI to Shearman & Sterling LLP from $4,842 of accounts payable to $4,000 of interest-free and unsecured promissory note, payable in four equal tranches. Subsequently, the promissory note was amended upon payment of $1,500, wherein the balance $2,500 was promised to be paid in two equal tranches. $2,500 owed to Sherman & Sterling LLP has been disclosed as short-term debt, as ATI has an unconditional obligation to settle it within twelve months from December 31, 2023.
	AERT	Insurance For Its Directors InsuranceForItsDirectors	After the Closing Date, ATI obtained an insurance policy for its directors and senior officers with maximum coverage of $5,000. The total premium payable in relation to this was $880 out of which $176 was paid upfront and balance $704 is payable in ten equal monthly instalments of $73. The arrangement represents a financing transaction where the premium payable has been deferred. The interest rate under the arrangement is 9.2 % per annum. The cumulative interest payable throughout the tenure under the arrangement amounts to $30 and the same would be recognized as part of the interest expense in the condensed consolidated statement of operations. During the nine months and three months ended December 31, 2023, the interest expense so recognized was $10. The balance premium payable as at December 31, 2023 is $641 and has been disclosed as a current liability since ATI has an unconditional obligation to settle it by September 2024.
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1141000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	969000	usd
CY2022Q4	AERT	Exchange Rate ExchangeRate	138000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.1075	pure
CY2023Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P48M
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	3000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	850000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	15000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	286000	usd
CY2023Q4	AERT	Total Future Maturities Of Debt TotalFutureMaturitiesOfDebt	1154000	usd
CY2023Q4	us-gaap	Revenues Revenues	18897000	usd
CY2022Q4	us-gaap	Revenues Revenues	12691000	usd
	us-gaap	Revenues Revenues	52805000	usd
	us-gaap	Revenues Revenues	38027000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1564000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	181000	usd
	us-gaap	Deferred Income Revenue Recognized DeferredIncomeRevenueRecognized	228000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	155000	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	193000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2023Q4	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	-14000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	-86000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	100000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax	-51000	usd
CY2023Q4	AERT	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-21000	usd
CY2022Q4	AERT	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-15000	usd
	AERT	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-64000	usd
	AERT	Amortization Of Net Actuarial Loss Gain AmortizationOfNetActuarialLossGain	-47000	usd
CY2023Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9000	usd
CY2022Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	25000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	25000	usd
CY2023Q4	AERT	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-26000	usd
CY2022Q4	AERT	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-76000	usd
	AERT	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	27000	usd
	AERT	Unrecognized Actuarial Gain Loss On Employee Benefit Plan Obligations UnrecognizedActuarialGainLossOnEmployeeBenefitPlanObligations	-73000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	112000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	83000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	338000	usd
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	255000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	24000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	13000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	74000	usd
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	39000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	21000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	15000	usd
	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	64000	usd
	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	47000	usd
CY2023Q4	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	157000	usd
CY2022Q4	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	111000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	476000	usd
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	341000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.108	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.583	pure
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.035	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.738	pure
CY2020Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59900	shares
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59900	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	295565	shares
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.4080	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0301	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
	AERT	Stockbased Compensation Expense StockbasedCompensationExpense	1626000	usd
	AERT	Stockbased Compensation Expense StockbasedCompensationExpense	2482000	usd
CY2023Q4	AERT	Stockbased Compensation Expense StockbasedCompensationExpense	0	usd
CY2022Q4	AERT	Stockbased Compensation Expense StockbasedCompensationExpense	1425000	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0	usd
	AERT	Unrecognized Stockbased Compensation Cost UnrecognizedStockbasedCompensationCost	0	usd
	AERT	Unrecognized Stockbased Compensation Cost UnrecognizedStockbasedCompensationCost	3050000	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	200000	shares
CY2023Q1	AERT	Exchange Rate ExchangeRate	2433000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	2000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	9000	usd
CY2021Q4	AERT	Initial Public Offering Description InitialPublicOfferingDescription	the consummation of the Initial Public Offering (IPO), the Company issued 11,499,991 Public Warrants. Simultaneously with the closing of the IPO, WWAC issued 8,900,000 warrants in a private placement (the “Private Placement Warrants”), at a purchase price of $1.00 per Private Placement Warrant, which included 900,000 Units as a result of the underwriter’s full exercise of its option to purchase up to 900,000 additional warrants, at a purchase price of $1.00 per Private Placement Warrant. On November 6, 2023, WWAC issued 627,810 other Private Placement Warrants to the Sponsor pursuant to the conversion of a promissory note payable to the Sponsor. Upon consummation of the Business Combination, the Company assumed 11,499,991 Public Warrants and 9,527,810 Private Placement Warrants (collectively the “Warrants”).
CY2023Q4	AERT	Sale Price SalePrice	18.00
CY2023Q4	AERT	Sale Price SalePrice	18.00
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10	shares
	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	10000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000	shares
	AERT	Warrants And Forward Purchase Agreement Put Option Liability Acquired As Part Of Business Combination WarrantsAndForwardPurchaseAgreementPutOptionLiabilityAcquiredAsPartOfBusinessCombination	27778000	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings	16395000	usd
CY2023Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	44173000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16626000	usd
	AERT	Weighted Average Shares Outstanding Of Class Ordinary Shares Basic And Diluted WeightedAverageSharesOutstandingOfClassOrdinarySharesBasicAndDiluted	15389062	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08

Files In Submission

Name	View Source	Status
0001829126-24-001000-index-headers.html	Edgar Link	pending
0001829126-24-001000-index.html	Edgar Link	pending
0001829126-24-001000.txt	Edgar Link	pending
0001829126-24-001000-xbrl.zip	Edgar Link	pending
aeriestech_10q.htm	Edgar Link	pending
aeriestech_ex31-1.htm	Edgar Link	pending
aeriestech_ex31-2.htm	Edgar Link	pending
aeriestech_ex32-1.htm	Edgar Link	pending
aeriestech_ex32-2.htm	Edgar Link	pending
aert-20231231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
aert-20231231_def.xml	Edgar Link	unprocessable
aert-20231231_lab.xml	Edgar Link	unprocessable
aert-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
aeriestech_10q_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
aert-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AERT
Aeries Technology, Inc. Stock $aert

2023 Q4 Form 10-Q Financial Statement

#000182912624001000 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AERT Aeries Technology, Inc. Stock $aert

2023 Q4 Form 10-Q Financial Statement

#000182912624001000 Filed on February 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AERT
Aeries Technology, Inc. Stock $aert